Treatment of the insulin resistance syndrome with selective CGMP PDE5 inhibitors

Details for Australian Patent Application No. 2001276607 (hide)

Inventors Fryburg, David Albert; Koppiker, Nandan Parmanand; Gibbs, Earl Michael

Agent Spruson & Ferguson

Event Publications

9 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001276608

2001276606-Pseudo-metalloproteins, corresponding preparation and use as biosensors